Human Metabolome Technologies Posts Profit Decline but Maintains Strong Capital Base

Human Metabolome Technologies, Inc. ( (JP:6090) ) has issued an announcement.

Human Metabolome Technologies, Inc., listed on the Tokyo Standard market, operates in the life-science analytics and metabolomics sector, supplying analytical technologies and services to pharmaceutical, biotech, and research institutions. Its offerings support drug discovery, biomarker development, and diagnostic research, positioning the company in a specialized niche of the healthcare and biotech value chain.

For the third quarter ended March 2026, Human Metabolome Technologies reported a 12.6% year-on-year decline in net sales to ¥1,107 million and a sharp drop in profitability, with operating profit down 41.1% and profit attributable to owners of parent falling 45.6%. Despite weaker earnings, the company maintained a strong balance sheet with total assets of ¥2,287 million and a high capital adequacy ratio of 82.4%, while continuing its policy of paying no interim dividends during the current and prior fiscal years.

The company’s ordinary profit for the quarter decreased 38.8% from the previous year to ¥209 million, and basic earnings per share fell to ¥29.35 from ¥51.53, reflecting the earnings contraction. However, net assets remained relatively stable at ¥1,884 million compared with ¥1,908 million at the prior fiscal year-end, suggesting that while short-term performance has softened, the firm’s financial resilience and capital structure continue to provide a buffer for stakeholders.

More about Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc. is a Japan-listed general business company on the Tokyo Standard market, operating in the metabolomics and life-science analytics field. The company provides metabolome analysis technologies and related services, targeting pharmaceutical, biotechnology, and academic research customers that rely on metabolic profiling for drug discovery and diagnostics innovation.

Average Trading Volume: 8,119

Technical Sentiment Signal: Sell

Current Market Cap: Yen4.03B

For a thorough assessment of 6090 stock, go to TipRanks’ Stock Analysis page.